Herantis Pharma (OHEL:HRTIS) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OHEL:HRTIS Herantis Pharma PLC OHEL:HRTIS
27 GF Score
Price €1.63
! 3 Warning Signs
View Full Analysis

What is Herantis Pharma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


OHEL:HRTIS vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, Herantis Pharma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Herantis Pharma Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Herantis Pharma's Short Interest distribution charts can be found below:

* The bar in red indicates where Herantis Pharma's Short Interest falls into.


OHEL:HRTIS
27GF Score
Herantis Pharma PLC OHEL:HRTIS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Herantis Pharma Business Description

Address Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinsons disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.
27GF Score

Get the complete analysis for OHEL:HRTIS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.63
Price